Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic Infection

Kojiro Michitaka; Atsushi Hiraoka; Yoshio Tokumoto; Keiko Ninomiya; Tomoyuki Ninomiya; Norio Horiike; Masanori Abe; Yoichi Hiasa
January 2014
International Journal of Hepatology;2014, p1
Academic Journal
Information regarding the progression of acute hepatitis B virus (HBV) infection to chronic infection in adults is scarce. Methods. Twenty-five adult patients with acute HBV infection (14 men and 11 women, 18-84 years old), whose clinical features progressed to those of chronic infection (group A) or did not (group B), were studied retrospectively. Results. There were 3 and 22 patients in groups A and B, respectively. Two of the 3 patients of group A lacked the typical symptoms of acute hepatitis. No differences were found between groups with respect to age, sex, or HBV genotypes. However, total bilirubin and alanine aminotransaminase levels were significantly lower in group A. Conclusions. Three of the 25 adult patients with acute HBV infection progressed to chronic infection. Hepatitis was mild in these patients. Patients with mild acute hepatitis B or unapparent HBV infection may have a higher risk of progressing to chronic infection.


Related Articles

  • Improving the identification of priority populations to increase hepatitis B testing rates, 2012. van Gemert, Caroline; Julie Wang; Simmons, Jody; Cowie, Benjamin; Boyle, Douglas; Stoove, Mark; Enright, Chris; Hellard, Margaret; Wang, Julie // BMC Public Health;2/1/2016, Vol. 16 Issue 1, p1 

    Background: It is estimated that over 40 % of the 218,000 people with chronic hepatitis B (CHB) in Australia in 2011 are undiagnosed. A disproportionate number of those with undiagnosed infection were born in the Asia-Pacific region. Undiagnosed CHB can lead to ongoing transmission...

  • Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients. Tsuge, Masataka; Murakami, Eisuke; Imamura, Michio; Abe, Hiromi; Miki, Daiki; Hiraga, Nobuhiko; Takahashi, Shoichi; Ochi, Hidenori; Nelson Hayes, C.; Ginba, Hiroyuki; Matsuyama, Kazuhiro; Kawakami, Hiroiku; Chayama, Kazuaki // Journal of Gastroenterology;Oct2013, Vol. 48 Issue 10, p1188 

    Background: Treatment for chronic hepatitis B has improved drastically with the use of nucleot(s)ide analogues (NAs). However, NA therapy typically fails to eliminate Hepatitis B virus (HBV) completely, and it is difficult to discontinue these therapies. We previously demonstrated that NA...

  • Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B. Ching-Lung Lai; Sang Hoon Ahn; Kwan Sik Lee; Soon Ho Um; Mong Cho; Seung Kew Yoon; Jin-Woo Lee; Neung Hwa Park; Young-Oh Kweon; Joo Hyun Sohn; Jiyoon Lee; Jeong-Ae Kim; Kwang-Hyub Han; Man-Fung Yuen // Gut;Jun2014, Vol. 63 Issue 6, p996 

    Background Besifovir (LB80380) is an acyclic nucleotide phosphonate effective in hepatitis B virus (HBV) DNA suppression for both treatment-naive and lamivudine-resistant chronic hepatitis B (CHB) patients in preliminary studies. Design We aimed to compare the safety and antiviral activity of...

  • Significant Fibrosis Is Not Rare in Chinese Chronic Hepatitis B Patients with Persistent Normal ALT. Liao, Baolin; Wang, Zhanhui; Lin, Siwei; Xu, Ying; Yi, Junqing; Xu, Min; Huang, Zuxiong; Zhou, Ying; Zhang, Fuchun; Hou, Jinlin // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background:Limited studies have been done on chronic hepatitis B (CHB) patients defined according to the latest Asian-Pacific Association for the Study of the Liver guideline with liver histology by a large sample size. Methods:We retrospectively evaluated liver histological characteristics...

  • Efficacy of entecavir treatment among chronic hepatitis B nucleos(t)ide-naïve and -experienced patients. Çağatay BİÇER, Kadir; ARI, Alpay; GENÇ, Vecdi Evren; CAYMAZ, Sibel ÖZSU; AVCI, Meltem; BAL, Fatma // Turkish Journal of Medical Sciences;2015, Vol. 45 Issue 1, p99 

    Background/aim: To evaluate the efficacy of entecavir (ETV) among chronic hepatitis B (CHB) nucleos(t)ide-naïve and -experienced patients in clinical practice. Materials and methods: In this retrospective study 85 CHB patients who had been receiving ETV and who attended our clinic since 2007...

  • Significance of ICGR<15 and EHBF in evaluating liver reserve function among patients with chronic hepatitis. QIN Hua; WANG Wenheng; WANG Zhanlan // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;2014, Vol. 30 Issue 2, p141 

    To investigate the clinical values of indocyanine green (ICG) retention rate at 15 min (ICGR15) and effective hepatic blood flow (EHBF) in evaluating the liver reserve function among patients with chronic hepatitis. Methods Eighty - two patients with chronic hepatitis were included in the study....

  • Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings. Spradling, Philip R.; Jian Xing; Rupp, Loralee B.; Moorman, Anne C.; Gordon, Stuart C.; Teshale, Eyasu T.; Mei Lu; Boscarino, Joseph A.; Trinacty, Connie M.; Schmidt, Mark A.; Holmberg, Scott D. // Clinical Infectious Diseases;11/1/2016, Vol. 63 Issue 9, p1205 

    Among 2338 chronic hepatitis B patients followed during 2006-2013 in the Chronic Hepatitis Cohort Study, 78% had ≥1 alanine aminotransferase and 37% had ≥1 hepatitis B virus DNA level assessed annually. Among cirrhotic patients, 46% never had hepatic imaging. Patients in this cohort...

  • Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea. Kwon, Jung Hyun; Song, Myeong Jun; Jang, Jeong Won; Bae, Si Hyun; Choi, Jong Young; Yoon, Seung Kew; Kim, Hee Yeon; Kim, Chang Wook; Song, Do Seon; Chang, U. Im; Yang, Jin Mo; You, Chan Ran; Choi, Sang Wook; Lee, Hae Lim; Lee, Sung Won; Han, Nam Ik; Nam, Soon Woo; Kim, Sang Gyune; Kim, Young Seok; Kim, Seok Hyun // Digestive Diseases & Sciences;Jul2019, Vol. 64 Issue 7, p2039 

    Aims: To evaluate the efficacy and safety of 144-week tenofovir disoproxil fumarate (TDF) therapy in treatment-naïve chronic hepatitis B (CHB) patients in Korean.Methods: In total, 579 treatment-naïve CHB patients at 11 medical centers were enrolled retrospective...

  • Soluble ST2 Plasma Concentrations Predict Mortality in HBV-Related Acute-on-Chronic Liver Failure. Lei, Ziying; Mo, Zhishuo; Zhu, Jianyun; Pang, Xiuqing; Zheng, Xingrong; Wu, Zhebin; Wang, Ke; Li, Xinhua; Xie, Dongying; Gao, Zhiliang // Mediators of Inflammation;3/29/2015, Vol. 2015, p1 

    Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a rapidly progressing and frequently fatal condition. The aim of this study was to determine whether interleukin- (IL-) 33 and soluble ST2 (sST2) were associated with disease severity and mortality in HBV-ACLF. We found that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics